Hi,
I am quite new to immunology and need some help with designing assays to test the alloreactivity to a particular type of cells in vitro. The goal of my study is to evaluate the suitability of a particular cell type for potential human transplantation. It is a very early study and I have to first show that the cells are not highly immunogenic. I prefer to use in vitro assays rather than animal assays due to resource constraints as well as ethical considerations.
From my reading up of the literature, I gathered that there are two common assays to quantify the alloreactivity to a particular cell population - PBMC proliferation assay and T-cell activation assay.
T-cell activation is measured by the expression of cytotoxic molecules by T-cells such as granzyme B and perforin. It is normally performed using purified CD3+ pan T-cells.
My questions are:
1) Is it possible to use whole blood mononuclear cells to do T-cell activation assays? Since whole blood MNCs contain 45-70% CD3+ T-cells, wouldn't it be possible to quantify the number of granzyme B and perforin expressing cells on gated CD3+ T-cell populations?
2) What is the minimum number of individual donor PBMCs or T-cells samples that needs to be tested to make the results statistically acceptable?
3) Are there any non-cell based assays e.g. PCR-based assays that can be used to predict the alloreactivity of a particular cell population?
I would appeciate it greatly is anyone could help shed some light on these questions.
Many thanks.
-neuropath-
